SEMABIZ, Inc. | ChosaReport.com

日本と海外の市場調査レポート＆サービスを取り扱っております。

欧州の神経血管デバイス / インターベンショナル神経学市場

出版：Inkwood Research

EUROPE NEUROVASCULAR DEVICES / INTERVENTIONAL NEUROLOGY MARKET FORECAST 2021-2028欧州の神経血管デバイス / インターベンショナル神経学市場
種別英文調査報告書
出版Inkwood Research
出版年月2021年7 月
ページ数169
価格
シングルユーザライセンスUSD 1,250
マルチユーザライセンスUSD 1,500
エンタープライズライセンスUSD 2,000
–

このレポートへお問合せ　　　レポート目次

Inkwood Research「EUROPE NEUROVASCULAR DEVICES / INTERVENTIONAL NEUROLOGY MARKET FORECAST」は欧州の神経血管デバイス / インターベンショナル神経学市場を分析・予測した市場調査レポートです。KEY FINDINGSThe Europe neurovascular devices / interventional neurology market growth is anticipated to progress at a CAGR of 4.87% during the forecast period, 2021-2028. The surging prevalence of neurovascular diseases boosts the market growth. For instance, there will be a 34% increase in stroke incidences between 2015 and 2035, as per the Stroke Alliance for Europe.MARKET INSIGHTSPoland, Italy, the United Kingdom, Germany, Belgium, Russia, France, and Rest of Europe, are evaluated for the Europe neurovascular devices / interventional neurology market growth analysis. Germany has a world-class healthcare system that offers cost-effective treatment. As per The Burden of Stroke in Europe report by the King’s College, London, the stroke incidence rate is 51.7 per 100,000 in the country. Also, Germany has a considerable mortality rate due to stroke, with almost 75,861 deaths annually. With an expectant increase in such incidences, the demand for neurovascular diseases is projected to increase during the forecast period.In Italy, the healthcare system is witnessing growth with developments in neurology. As per the XLVII Congress of the Italian Society of Neurology’s report, more than 1 million have dementia. Every year 120,000 people are affected by stroke, and another 930,000 are affected by the disability caused by stroke. Also, Italy has a growing senior population, contributing to increasing cases of neurological disorders like Parkinson’s disease and multiple sclerosis. In Spain, stroke is the third leading cause of death after Alzheimer’s disease and ischemic heart stroke. Also, the government has increased its investment in healthcare systems. Such factors facilitate market growth in these countries.COMPETITIVE INSIGHTSSome of the eminent firms in the market are B Braun Melsungen AG, Phenox GmbH, Rapid Medical, Microport Scientific Corporation, Kaneka Corporation, etc.Our report offerings include:• Explore key findings of the overall market• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions• Market Segmentation cater to a thorough assessment of key segments with their market estimations• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

目次


Table of Contents

TABLE OF CONTENTS1. RESEARCH SCOPE & METHODOLOGY1.1. STUDY OBJECTIVES1.2. SCOPE OF STUDY1.3. METHODOLOGY1.4. ASSUMPTIONS & LIMITATIONS2. EXECUTIVE SUMMARY2.1. MARKET SIZE & ESTIMATES2.2. MARKET OVERVIEW3. MARKET DYNAMICS3.1. KEY DRIVERS3.1.1. INCIDENCE OF NEUROVASCULAR CONDITIONS3.1.2. DEMAND FOR MINIMALLY INVASIVE PROCEDURES3.1.3. SIGNIFICANCE OF NEUROLOGICAL DISEASES IN GERIATRIC POPULATION3.1.4. PREVALENCE OF UNDERLYING DISEASE CONDITIONS 3.2. KEY RESTRAINTS3.2.1. EXORBITANT COST OF NEUROVASCULAR DEVICES3.2.2. LACK OF ADEQUATE NUMBER OF TRAINED NEUROSURGEONS4. KEY ANALYTICS4.1. IMPACT OF COVID-19 ON NEUROVASCULAR DEVICES MARKET4.2. KEY MARKET TRENDS4.3. PORTER’S FIVE FORCES ANALYSIS4.3.1. BUYERS POWER4.3.2. SUPPLIERS POWER4.3.3. SUBSTITUTION4.3.4. NEW ENTRY4.3.5. INDUSTRY RIVALRY4.4. OPPORTUNITY MATRIX4.5. VENDOR LANDSCAPE5. MARKET BY PRODUCT5.1. EMBOLIZATION DEVICES5.2. ACCESSORY DEVICES5.3. REVASCULARIZATION DEVICES5.4. THROMBECTOMY DEVICES5.5. EMBOLIC PROTECTION DEVICES6. MARKET BY APPLICATION6.1. ANEURYSM6.2. ISCHEMIC STROKE6.3. STENOSIS6.4. ARTERIOVENOUS MALFORMATION (AVM)6.5. OTHER APPLICATIONS7. GEOGRAPHICAL ANALYSIS7.1. EUROPE7.1.1. MARKET SIZE & ESTIMATES7.1.2. KEY GROWTH ENABLERS7.1.3. KEY CHALLENGES7.1.4. KEY PLAYERS7.1.5. COUNTRY ANALYSIS7.1.5.1. GERMANY7.1.5.2. UNITED KINGDOM7.1.5.3. FRANCE7.1.5.4. ITALY7.1.5.5. RUSSIA7.1.5.6. POLAND7.1.5.7. BELGIUM7.1.5.8. REST OF EUROPE8. COMPETITIVE LANDSCAPE8.1. KEY STRATEGIC DEVELOPMENTS8.1.1. MERGERS & ACQUISITIONS8.1.2. PRODUCT LAUNCHES & DEVELOPMENTS8.1.3. PARTNERSHIPS & AGREEMENTS8.1.4. BUSINESS EXPANSIONS, ANNOUNCEMENTS & DIVESTITURES8.2. COMPANY PROFILES8.2.1. ACANDIS GMBH8.2.2. ASAHI INTECC8.2.3. B BRAUN MELSUNGEN AG8.2.4. INTEGER HOLDINGS CORPORATION8.2.5. JOHNSON & JOHNSON (CERENOVUS)8.2.6. KANEKA CORPORATION8.2.7. MEDTRONIC INC8.2.8. MEMRY CORPORATION8.2.9. MICROPORT SCIENTIFIC CORPORATION8.2.10. PENUMBRA INC8.2.11. PHENOX GMBH8.2.12. RAPID MEDICAL8.2.13. SENSOME8.2.14. STRYKER CORPORATION8.2.15. TERUMO MEDICAL CORPORATION (MICROVENTION INC)

List of Tables

LIST OF TABLESTABLE 1: MARKET SNAPSHOT – NEUROVASCULAR DEVICESTABLE 2: EUROPE NEUROVASCULAR DEVICES MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)TABLE 3: EUROPE NEUROVASCULAR DEVICES MARKET, BY PRODUCT, FORECAST YEARS, 2021-2028 (IN $ MILLION)TABLE 4: EUROPE NEUROVASCULAR DEVICES MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)TABLE 5: EUROPE NEUROVASCULAR DEVICES MARKET, BY APPLICATION, FORECAST YEARS, 2021-2028 (IN $ MILLION)TABLE 6: EUROPE NEUROVASCULAR DEVICES MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)TABLE 7: EUROPE NEUROVASCULAR DEVICES MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)TABLE 8: LEADING PLAYERS OPERATING IN THE EUROPE NEUROVASCULAR DEVICES MARKETTABLE 9: LIST OF MERGERS & ACQUISITIONSTABLE 10: LIST OF PRODUCT LAUNCHES & DEVELOPMENTSTABLE 11: LIST OF PARTNERSHIPS & AGREEMENTSTABLE 12: LIST OF BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES

List of Figures

LIST OF FIGURESFIGURE 1: KEY MARKET TRENDSFIGURE 2: PORTER’S FIVE FORCES ANALYSISFIGURE 3: OPPORTUNITY MATRIXFIGURE 4: VENDOR LANDSCAPEFIGURE 5: EUROPE NEUROVASCULAR DEVICES MARKET, BY PRODUCT, IN 2020FIGURE 6: EUROPE NEUROVASCULAR DEVICES MARKET, BY EMBOLIZATION DEVICES, 2021-2028 (IN $ MILLION)FIGURE 7: EUROPE NEUROVASCULAR DEVICES MARKET, BY ACCESSORY DEVICES, 2021-2028 (IN $ MILLION)FIGURE 8: EUROPE NEUROVASCULAR DEVICES MARKET, BY REVASCULARIZATION DEVICES, 2021-2028 (IN $ MILLION)FIGURE 9: EUROPE NEUROVASCULAR DEVICES MARKET, BY THROMBECTOMY DEVICES, 2021-2028 (IN $ MILLION)FIGURE 10: EUROPE NEUROVASCULAR DEVICES MARKET, BY EMBOLIC PROTECTION DEVICES, 2021-2028 (IN $ MILLION)FIGURE 11: EUROPE NEUROVASCULAR DEVICES MARKET, BY APPLICATION, IN 2020FIGURE 12: EUROPE NEUROVASCULAR DEVICES MARKET, BY ANEURYSM, 2021-2028 (IN $ MILLION)FIGURE 13: EUROPE NEUROVASCULAR DEVICES MARKET, BY ISCHEMIC STROKE, 2021-2028 (IN $ MILLION)FIGURE 14: EUROPE NEUROVASCULAR DEVICES MARKET, BY STENOSIS, 2021-2028 (IN $ MILLION)FIGURE 15: EUROPE NEUROVASCULAR DEVICES MARKET, BY ARTERIOVENOUS MALFORMATION (AVM), 2021-2028 (IN $ MILLION)FIGURE 16: EUROPE NEUROVASCULAR DEVICES MARKET, BY OTHER APPLICATIONS, 2021-2028 (IN $ MILLION)FIGURE 17: EUROPE NEUROVASCULAR DEVICES MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)FIGURE 18: GERMANY NEUROVASCULAR DEVICES MARKET, 2021-2028 (IN $ MILLION)FIGURE 19: UNITED KINGDOM NEUROVASCULAR DEVICES MARKET, 2021-2028 (IN $ MILLION)FIGURE 20: FRANCE NEUROVASCULAR DEVICES MARKET, 2021-2028 (IN $ MILLION)FIGURE 21: ITALY NEUROVASCULAR DEVICES MARKET, 2021-2028 (IN $ MILLION)FIGURE 22: RUSSIA NEUROVASCULAR DEVICES MARKET, 2021-2028 (IN $ MILLION)FIGURE 23: POLAND NEUROVASCULAR DEVICES MARKET, 2021-2028 (IN $ MILLION)FIGURE 24: BELGIUM NEUROVASCULAR DEVICES MARKET, 2021-2028 (IN $ MILLION)FIGURE 25: REST OF EUROPE NEUROVASCULAR DEVICES MARKET, 2021-2028 (IN $ MILLION)

お問合せフォーム

    お問合せフォーム

    • *のある項目は必須項目です。

    • レポートのタイトルは自動で入ります。

    • 無料サンプルはご購入を検討されている方向けのレポート形式等確認用資料です。
      重要記述や数値は記載されていません。予めご了承ください。

    お名前*

    会社名*

    部署名

    メールアドレス*

    電話番号

    当ウェブサイトを知った経緯を教えてください。

    お問合せ内容

    株式会社SEMABIZ・ChosaReport.com プライバシーポリシー

    Eメールでのお問合せもお受けしております。
    下記アドレスへ“(at)”を“@”に変えてお送りください。通常1営業日以内にご返信いたします。
    crinquiry(at)chosareport.com

    医療・医薬の最新記事8件